HEMOSTATIC ALTERATIONS DURING BRUTON KINASE INHIBITORS TREATMENT

Patients with chronic lymphocytic leukemia (CLL) are at increased risk for major bleeding compared with the general population. The hazard ratio (HR) for major bleeding among 6,717 treated CLL/SLL patients compared with 14816 matched noncancer patients was 8.3 (95% confidence interval [CI]: 7.5-9.2...

Full description

Bibliographic Details
Published in:Haematologica
Main Author: M. Carpenedo
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-10-01
Online Access:https://haematologica.org/article/view/12916